TY - JOUR
T1 - Analysis of overall gene expression induced by amphetamine and phencyclidine
T2 - Novel targets for the treatment of drug psychosis and schizophrenia
AU - Ito, Chihiro
PY - 2002
Y1 - 2002
N2 - Although the etiology of drug psychosis or schizophrenia is still unknown, molecular and biochemical researches have recently made significant advances in the search for the candidate genes of these disorders. Among such studies are animal models of drug psychosis or schizophrenia such as amphetamine-induced behavioral sensitization or phencyclidine-treated animals. In this review, it is suggested that amphetamine or phencyclidine change the gene expressions related to not only neurotransmistter systems such as dopamine or glutamic acid, transcription factors, cell proliferation, apoptosis, cell adhesion, but also the synapse. These alterable gene expressions may lead to the discovery of candidate genes of drug psychosis or schizophrenia and thus to novel antipsychotics.
AB - Although the etiology of drug psychosis or schizophrenia is still unknown, molecular and biochemical researches have recently made significant advances in the search for the candidate genes of these disorders. Among such studies are animal models of drug psychosis or schizophrenia such as amphetamine-induced behavioral sensitization or phencyclidine-treated animals. In this review, it is suggested that amphetamine or phencyclidine change the gene expressions related to not only neurotransmistter systems such as dopamine or glutamic acid, transcription factors, cell proliferation, apoptosis, cell adhesion, but also the synapse. These alterable gene expressions may lead to the discovery of candidate genes of drug psychosis or schizophrenia and thus to novel antipsychotics.
UR - http://www.scopus.com/inward/record.url?scp=0036237416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036237416&partnerID=8YFLogxK
U2 - 10.2174/1381612023396528
DO - 10.2174/1381612023396528
M3 - Article
C2 - 11812256
AN - SCOPUS:0036237416
SN - 1381-6128
VL - 8
SP - 147
EP - 153
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 2
ER -